BioCardia, Inc.
BCDA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000925741
In the last 90 days, BioCardia, Inc. insiders filed 9 open-market purchases and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.65M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in BioCardia, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- +3 vs. Q1 2026
- Shares held
- 1.33M
- +646.8K (+94.2%) vs. Q1 2026
- Total value
- $1.65M
- +$815.9K (+98.2%) vs. Q1 2026
- New holders
- 8
- 4 more added
- Sold out
- 5
- 3 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BCDA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 21 | $1.65M |
| Q1 2026 | 18 | $831.1K |
| Q4 2025 | 20 | $812.3K |
| Q3 2025 | 18 | $551.9K |
| Q2 2025 | 16 | $593.2K |
| Q1 2025 | 12 | $623.8K |
| Q4 2024 | 13 | $272.2K |
| Q3 2024 | 9 | $316.6K |
| Q2 2024 | 10 | $227.8K |
| Q1 2024 | 22 | $790.8K |
| Q4 2023 | 24 | $1.37M |
| Q3 2023 | 16 | $709.6K |
| Q2 2023 | 23 | $4.43M |
| Q1 2023 | 23 | $4.09M |
| Q4 2022 | 25 | $4.87M |
| Q3 2022 | 23 | $3.17M |
| Q2 2022 | 26 | $3.10M |
| Q1 2022 | 24 | $5.49M |
| Q4 2021 | 23 | $5.78M |
| Q3 2021 | 22 | $9.01M |
| Q2 2021 | 20 | $12.3M |
| Q1 2021 | 19 | $13.5M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding BioCardia, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Advisor Group Holdings, Inc. | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Caitong International Asset Management Co., Ltd | 1 | $1 | 0.00% | +1 | New |
| SBI Securities Co., Ltd. | 9 | $11 | 0.00% | 00.0% | Unchanged |
| Global Retirement Partners, LLC | 411 | $510 | 0.00% | +411 | New |
| Allied Private Wealth LLC | 1,449 | $1.40K | 0.00% | +1,449 | New |
| Morgan Stanley | 3,105 | $3.85K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 3,187 | $3.95K | 0.00% | +209+7.0% | Added |
| Gsa Capital Partners LLP | 12,862 | $16.0K | 0.00% | +12,862 | New |
| Wealth Enhancement Advisory Services, LLC | 18,500 | $16.9K | 0.00% | +18,500 | New |
| StoneX Group Inc. | 20,020 | $24.8K | 0.00% | +20,020 | New |
| Citadel Advisors LLC | 22,956 | $28.5K | 0.00% | −40,428−63.8% | Reduced |
| Commonwealth Equity Services, LLC | 23,383 | $29.0K | 0.00% | +5,100+27.9% | Added |
| Brown Advisory Inc | 35,538 | $44.1K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 38,809 | $48.1K | 0.00% | −180.0% | Reduced |
| Vanguard Fiduciary Trust Co | 66,270 | $82.2K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 66,664 | $82.7K | 0.00% | −27,623−29.3% | Reduced |
| UBS Group AG | 77,619 | $96.2K | 0.00% | +77,619 | New |
| Pingora Partners LLC | 120,382 | $149.3K | 0.09% | +84,643+236.8% | Added |
| Vanguard Capital Management LLC | 124,591 | $154.5K | 0.00% | 00.0% | Unchanged |
| CM Management, LLC | 300,000 | $372.0K | 0.24% | +170,000+130.8% | Added |
| Citigroup Inc | 397,594 | $493.0K | 0.00% | +397,594 | New |
| XTX Topco Ltd | 0 | $0 | 0.00% | −24,270−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −20,355−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −14,780−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −13,900−100.0% | Sold out |
| Vanguard Global Advisers, LLC | 0 | $0 | 0.00% | −268−100.0% | Sold out |